
Hidehito Horinouchi and Fabian J. Bolte
Apr 3, 2025, 09:27
Hidehito Horinouchi: Real-World Outcomes of Tarlatamab in SCLC
Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared an article Fabian J. Bolte and his colleagues authored on X:
“Real-World Outcomes of Tarlatamab in SCLC.
Special considerations are required for patients with brain metastasis due to the increased risk of severe.
Dr. Fabian J. Bolte.”
Authors: Fabian J. Bolte et al.
Further Reading:
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 3, 2025, 09:29
Apr 3, 2025, 09:27
Apr 3, 2025, 09:16
Apr 3, 2025, 09:13
Apr 3, 2025, 08:47